miR-34a-dependent overexpression of Per1 decreases cholangiocarcinoma growth
- 1 June 2016
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 64 (6) , 1295-1304
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Genomic and Genetic Characterization of Cholangiocarcinoma Identifies Therapeutic Targets for Tyrosine Kinase InhibitorsGastroenterology, 2012
- Melatonin exerts by an autocrine loop antiproliferative effects in cholangiocarcinoma; its synthesis is reduced favoring cholangiocarcinoma growthAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2011
- Inhibition of histidine decarboxylase ablates the autocrine tumorigenic effects of histamine in human cholangiocarcinomaGut, 2011
- A Role for the Clock Gene Per1 in Prostate CancerCancer Research, 2009
- Circulating melatonin and the risk of breast and endometrial cancer in womenCancer Letters, 2009
- Integration of microRNA miR-122 in hepatic circadian gene expressionGenes & Development, 2009
- miR-34a repression of SIRT1 regulates apoptosisProceedings of the National Academy of Sciences, 2008
- Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cellsProceedings of the National Academy of Sciences, 2007
- MicroRNA-21 Regulates Expression of the PTEN Tumor Suppressor Gene in Human Hepatocellular CancerGastroenterology, 2007
- Circadian and CLOCK-controlled regulation of the mouse transcriptome and cell proliferationProceedings of the National Academy of Sciences, 2007